Related references
Note: Only part of the references are listed.Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
Jia Jia Liu et al.
MOLECULAR PSYCHIATRY (2020)
Interleukin-6: A Masterplayer in the Cytokine Network
Peter Uciechowski et al.
ONCOLOGY (2020)
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Inflammatory profiles of severe treatment-resistant depression
Rebecca Strawbridge et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder
Zhang Jun et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Emanuele Felice Osimo et al.
PSYCHOLOGICAL MEDICINE (2019)
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
Gara Arteaga-Henriquez et al.
FRONTIERS IN PSYCHIATRY (2019)
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni et al.
TRANSLATIONAL PSYCHIATRY (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Joseph Firth et al.
LANCET PSYCHIATRY (2019)
Inflammation and depression: a causal or coincidental link to the pathophysiology?
Brian E. Leonard
ACTA NEUROPSYCHIATRICA (2018)
Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model - are we there yet?
Emmanuel Jesulola et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis
Sarah R. Horn et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Blood biomarkers and treatment response in major depression
Cristina Mora et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
Manish K. Jha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression
Wei Zou et al.
PLOS ONE (2018)
Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis
Magdalena Wiedlocha et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
Ebrahim Haroon et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Ana C. de Menezes Galvao et al.
FRONTIERS IN PSYCHIATRY (2018)
The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation
Larissa N. Dooley et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study
Chen Mu-Hong et al.
PSYCHIATRY RESEARCH (2018)
Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!
Michael P. Hengartner et al.
FRONTIERS IN PSYCHIATRY (2018)
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Circadian Rhythms in Plasma Brain-derived Neurotrophic Factor Differ in Men and Women
Sean W. Cain et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2017)
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
Minkyung Park et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Identifying fast-onset antidepressants using rodent models
M. J. Ramaker et al.
MOLECULAR PSYCHIATRY (2017)
The interface of depression and obesity
Nattinee Jantaratnotai et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2017)
Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression When Enough Is Enough
Charles R. Conway et al.
JAMA PSYCHIATRY (2017)
Evidence for the treatment of moderate depression: a systematic review
D. Aherne et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2017)
Harmine is an inflammatory inhibitor through the suppression of NF-kB signaling
Xin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Obesity and inflammation: the linking mechanism and the complications
Mohammed S. Ellulu et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Temporal Relationship between Serum Levels of Interleukin-6 and C-Reactive Protein in Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy
Junichi Saito et al.
AMERICAN JOURNAL OF PERINATOLOGY (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
BDNF isoforms: a round trip ticket between neurogenesis and serotonin?
Rocio Beatriz Foltran et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
The hallucinogenic world of tryptamines: an updated review
Ana Margarida Araujo et al.
ARCHIVES OF TOXICOLOGY (2015)
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
Rita Haapakoski et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Does escitalopram reduce neurotoxicity in major depression?
Angelos Halaris et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression
J. Verduijn et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
C-reactive protein and cortisol in drug-naive patients with short-illness-duration first episode major depressive disorder: Possible role of cortisol immunomodulatory action at early stage of the disease
Wieslaw Jerzy Cubala et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
Attila Szabo et al.
PLOS ONE (2014)
From Stress to Inflammation and Major Depressive Disorder: A Social Signal Transduction Theory of Depression
George M. Slavich et al.
PSYCHOLOGICAL BULLETIN (2014)
Personalized medicine in major depressive disorder - Opportunities and pitfalls
Diane B. Miller et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
Draulio B. de Araujo et al.
HUMAN BRAIN MAPPING (2012)
P-values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals
M. J. Knol et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression
Mariska Bot et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2011)
Recurrence in Major Depression: A Conceptual Analysis
Scott M. Monroe et al.
PSYCHOLOGICAL REVIEW (2011)
Is Depression an Inflammatory Disorder?
Charles L. Raison et al.
CURRENT PSYCHIATRY REPORTS (2011)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
Robert H. Howland
JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES (2009)
The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis
X. Schmit et al.
INFECTION (2008)
Interleukin-1β stimulates acute phase response and C-reactive protein synthesis by inducing an NFκB- and C/EBPβ-dependent autocrine interleukin-6 loop
Frank Kramer et al.
MOLECULAR IMMUNOLOGY (2008)
Antidepressant therapy and C-reactive protein levels
Sinead M. O'Brien et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Protein kinase C pathway is involved in transcriptional regulation of C-reactive protein synthesis in human hepatocytes
Y Ivashchenko et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
AJ Rush et al.
CONTROLLED CLINICAL TRIALS (2004)
Share Paper
